HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Touts Performance Of Olympic Advertising And Promotions

This article was originally published in The Tan Sheet

Executive Summary

P&G reports a 50% higher return on investment for promotions connected to the 2012 Summer Olympics games than conventional campaigns. The company, which collected awards for the ads by a media analytics firm, vows to build upon its success in future games.

You may also be interested in...



P&G Plans More Price Cuts In 2013, Defends Savings Plan

Procter & Gamble will slash prices on some products in the short term to halt U.S. market share erosion in categories where competitors did not previously raise prices. On the firm’s Q4 earnings call, executives defended their bullish growth and savings projections.

U.S. Olympic Teams Hoist P&G Brand In Vancouver, London Games

Procter & Gamble will sponsor "the most positively viewed sports property in the United States" under an alliance with the U.S. Olympic Committee

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124819

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel